Senti Biosciences (SNTI) Misses Q1 EPS by 14c

Senti Biosciences (NASDAQ: SNTI) reported Q1 EPS of ($0.14). Revenue for the quarter came in at $10 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Senti Biosciences (SNTI) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Getty Realty discloses separation terms for departing accounting officer
• CPS Technologies signs 80,000-sq-ft lease in Attleboro, Massachusetts